National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

ammonium tetrathiomolybdate
An ammonium salt with potential antiangiogenic and antitumor activities. Tetrathiomolybdate has been found to deplete systemic copper reserves through an unknown mechanism. This agent has been shown to inhibit the activities of cuproenzymes, including superoxide dismutase 1 (SOD1) and cytochrome c oxidase (COX), which may contribute to its antiangiogenic and antitumor effects. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:tetrathiomolybdate
Abbreviations:ammonium TM
ATM
ATTM



Previous:aminopterin, aminothiadiazole, amiodarone hydrochloride, AML mRNA plus lysate loaded autologous dendritic cell vaccine, Ammoidin
Next:ammonium trichlorotellurate, Amnesteem, amonafide dihydrochloride, amonafide L-malate, amoxicillin

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov